PTC Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.4 | 6.1 | 7.1 | 9.0 | – | – | |
| 6.8 | 4.5 | 3.7 | 5.9 | 5.8 | 3.6 | 5.0 | 6.4 | 8.8 | 6.5 | 8.0 | 9.0 | 6.4 | 8.8 | 8.7 | 10.6 | 8.8 | 10.7 | 7.7 | 6.3 | 5.3 | 5.2 | 4.7 | 4.6 | 5.2 | 4.0 | 4.6 | 3.7 | 2.1 | 2.2 | 2.4 | 2.6 | 3.2 | 4.3 | 2.5 | 2.2 | 3.0 | 3.5 | 6.8 | 7.4 | |
| 3.4 | 3.1 | 3.3 | 4.3 | 5.7 | 4.5 | 7.5 | 5.8 | 5.9 | 4.9 | 4.1 | 5.1 | 2.9 | 4.6 | 5.3 | 5.8 | 6.2 | 8.5 | 11.4 | 15.2 | 25.0 | 1,956.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.9 | 3.4 | 4.7 | 6.1 | 6.3 | 3.7 | 5.5 | 6.0 | 8.6 | 6.2 | 7.0 | 9.1 | 5.7 | 8.9 | 9.2 | 11.1 | 8.5 | 11.0 | 8.4 | 6.9 | 5.8 | 4.6 | 5.2 | 5.1 | 5.4 | 4.5 | 5.2 | 4.2 | 2.6 | 3.8 | 2.1 | 2.2 | 2.9 | 6.3 | 1.8 | 1.8 | 2.8 | 4.5 | 6.2 | 7.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.8 | 3.7 | 5.5 | 8.7 | – | 40.7 | |
| – | – | – | – | – | – | – | – | 6,367.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.5 | 5.6 | 12.0 | 14.9 | – | – | |
| -25.6% | -28.3% | -27.5% | -7.6% | -5.7% | -1.9% | 0.0% | -0.9% | 0.0% | -2.5% | -3.4% | -4.6% | -7.4% | -5.3% | -7.1% | -7.0% | -6.4% | -6.4% | -8.4% | -8.4% | -12.5% | -12.0% | -14.9% | -14.7% | -11.4% | -18.3% | -11.3% | -12.0% | -20.3% | -13.4% | -9.0% | -9.8% | -9.6% | -5.2% | 15.4% | 17.9% | 8.3% | 6.7% | -9.2% | -4.4% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -80.3% | -41.3% | 5.4% | 53.2% | 80.5% | 97.5% | 96.5% | 96.1% | 95.6% | 95.2% | 95.4% | 95.5% | 95.8% | 96.0% | 95.7% | 94.9% | 95.1% | 95.0% | 94.4% | 94.5% | 94.3% | 94.0% | 94.1% | 94.2% | 93.8% | 93.6% | 93.7% | 93.7% | 94.1% | 84.8% | 84.6% | 83.8% | 83.6% | 92.9% | 96.9% | 97.1% | 91.2% | 91.0% | 79.2% | 82.1% | |
| -221.0% | -159.7% | -132.8% | -78.2% | -66.9% | -33.1% | -24.4% | -19.5% | -25.4% | -43.7% | -64.1% | -72.1% | -71.9% | -78.6% | -82.4% | -132.8% | -113.9% | -113.4% | -101.5% | -73.8% | -78.4% | -69.5% | -63.7% | -57.7% | -48.4% | -64.8% | -62.8% | -73.4% | -80.9% | -47.2% | -39.9% | -22.3% | -15.2% | -37.5% | 40.2% | 40.7% | 43.6% | 49.5% | -8.2% | 11.5% | |
| -236.7% | -171.8% | -143.8% | -88.4% | -75.6% | -40.6% | -30.9% | -25.0% | -30.6% | -48.4% | -69.0% | -76.4% | -74.9% | -82.0% | -90.8% | -138.7% | -123.2% | -115.1% | -105.5% | -82.9% | -92.4% | -97.3% | -91.7% | -89.9% | -76.3% | -80.0% | -74.1% | -75.5% | -80.4% | -66.8% | -62.4% | -53.3% | -50.3% | -45.0% | 33.6% | 35.6% | 42.3% | 39.4% | -22.6% | -3.8% | |
| -173.8% | -127.4% | -102.5% | -44.9% | -33.2% | -6.8% | -0.2% | -5.7% | 0.1% | -16.3% | -27.5% | -41.5% | -47.9% | -46.9% | -61.5% | -74.0% | -56.4% | -68.0% | -65.1% | -52.9% | -66.4% | -62.5% | -69.5% | -68.3% | -58.7% | -72.9% | -52.4% | -44.4% | -43.0% | -29.8% | -21.5% | -25.6% | -30.4% | -22.6% | 38.3% | 38.6% | 25.1% | 23.8% | -62.5% | -33.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -118.6% | -118.8% | -128.9% | -63.9% | -73.4% | -50.5% | -46.0% | -22.9% | -20.3% | -36.5% | -35.3% | -43.6% | -33.5% | -42.3% | -55.3% | -75.4% | -86.4% | -90.9% | -155.2% | -198.9% | -433.6% | -36,432.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -57.7% | -52.8% | -52.3% | -28.3% | -29.1% | -20.2% | -18.2% | -12.0% | -7.6% | -11.4% | -14.1% | -16.5% | -13.5% | -15.5% | -18.9% | -29.2% | -20.2% | -19.8% | -21.5% | -19.0% | -22.7% | -27.0% | -29.0% | -30.8% | -33.7% | -32.8% | -35.5% | -46.2% | -50.9% | -33.1% | -32.4% | -25.0% | -24.6% | -21.3% | 22.4% | 23.9% | 28.4% | 23.5% | -6.5% | -1.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 75 | -93 | 85 | 18 | 59 | 15 | 108 | -75 | -56 | -75 | -252 | 20 | -210 | 31 | 191 | 161 | -124 | 109 | 292 | 263 | 251 | -332 | 297 | 285 | 190 | 376 | 416 | 377 | 422 | 1,520 | -247 | -354 | -224 | 1,601 | -1,178 | -714 | -372 | 1,626 | -529 | -441 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.4 | -0.8 | -0.4 | 1.8 | – | -2.5 | |
| 48.6% | 44.4% | 40.6% | 44.3% | 39.7% | 39.9% | 39.6% | 52.3% | 37.5% | 31.3% | 40.0% | 37.8% | 40.4% | 36.6% | 34.2% | 38.8% | 23.4% | 21.8% | 13.9% | 9.5% | 5.2% | 0.1% | -5.0% | -10.1% | -14.4% | -20.3% | -28.4% | -43.3% | -53.2% | -43.2% | -49.9% | -51.1% | -57.2% | -64.4% | -7.0% | -7.8% | -5.9% | -7.1% | -6.3% | -5.1% | |
| 0.9 | 1.2 | 1.4 | 1.2 | 1.4 | 1.3 | 1.4 | 0.6 | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 1.5 | 2.2 | 4.2 | 307.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -4.88 | -4.16 | -3.79 | -2.74 | -2.59 | -1.88 | -1.66 | -1.33 | -1.63 | -2.54 | -3.24 | -3.81 | -3.94 | -4.45 | -4.68 | -6.63 | -6.53 | -6.56 | -6.47 | -5.55 | -6.45 | -7.41 | -7.33 | -7.79 | -7.42 | -7.69 | -7.75 | -8.27 | -8.51 | -8.30 | -7.57 | -6.25 | -5.89 | -4.71 | 6.89 | 8.05 | 8.63 | 8.46 | -2.26 | -0.42 | |
| 2.06 | 2.42 | 2.63 | 3.10 | 3.43 | 4.63 | 5.38 | 5.30 | 5.33 | 5.26 | 4.70 | 4.99 | 5.26 | 5.43 | 5.16 | 4.78 | 5.30 | 5.70 | 6.13 | 6.70 | 6.97 | 7.62 | 8.00 | 8.66 | 9.72 | 9.62 | 10.45 | 10.96 | 10.59 | 12.42 | 12.13 | 11.74 | 11.71 | 10.45 | 20.52 | 22.58 | 20.42 | 21.45 | 10.02 | 10.96 | |
| 4.11 | 3.50 | 2.94 | 4.28 | 3.53 | 3.73 | 3.61 | 5.80 | 8.03 | 6.96 | 9.18 | 8.74 | 11.75 | 10.51 | 8.47 | 8.79 | 7.55 | 7.21 | 4.17 | 2.79 | 1.49 | 0.02 | -1.27 | -2.55 | -3.17 | -4.78 | -6.21 | -7.75 | -8.90 | -10.84 | -11.69 | -12.78 | -13.71 | -14.22 | -2.15 | -2.64 | -1.79 | -2.54 | -2.19 | -1.80 | |
| -3.58 | -3.08 | -2.70 | -1.39 | -1.14 | -0.31 | -0.01 | -0.30 | 0.01 | -0.86 | -1.29 | -2.07 | -2.52 | -2.55 | -3.17 | -3.53 | -2.99 | -3.88 | -3.99 | -3.55 | -4.63 | -4.76 | -5.55 | -5.91 | -5.71 | -7.01 | -5.47 | -4.87 | -4.55 | -3.70 | -2.61 | -3.00 | -3.56 | -2.36 | 7.86 | 8.71 | 5.12 | 5.10 | -6.26 | -3.61 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.